Disclosure regarding the invitation to shareholders for the EGM Regulatory DisclosuresBy adminJune 18, 2023
Disclosure regarding the invitation to shareholders for the EGM Regulatory DisclosuresBy adminJune 18, 2023
Disclosure regarding Rameda acquiring a selection of pharmaceutical products belong to diabetes and cholesterol treatment drugs Regulatory DisclosuresBy adminJune 1, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. finalizes acquisition of a portfolio of 11 fast-growing cardiometabolic products Corporate NewsBy adminJune 1, 2023